To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene KDM5ATABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
317 supporting clones for gene KDM5A back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
AL133921 amygdala .a 1 to 497 1 to 497   tiling clone,   497/497
(100 %)
4 diff
(99.2 %id)
BU182136 eye, retinoblastoma .a 71 to 951 23 to 911   available from MGC,   889/912
(97 %)
29 diff
(96.9 %id)
BC053893 Eye, retinoblastoma .a 72 to 3731 1 to 3659   available from MGC, AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 3659/3669
(99 %)
2 diff
(100.0 %id)
NM_001042603.1   .a 72 to 10906 1 to 10835 exact RefSeq,   10835/10835
(100 %)
0 diff
(100 %id)
BC048307 Eye, retinoblastoma .a 85 to 3742 1 to 3656   available from MGC, AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 3656/3657
(99 %)
4 diff
(99.9 %id)
BM558799 eye, retinoblastoma .a 86 to 981 1 to 905   available from MGC,   905/1053
(85 %)
32 diff
(97.0 %id)
BP315853 mammary gland .a 200 to 784 1 to 583       583/583
(100 %)
5 diff
(99.2 %id)
DB152373 thymus .a 207 to 804 2 to 600   capped   599/599
(100 %)
3 diff
(99.5 %id)
DB078606 testis .a 211 to 784 2 to 574   capped   573/573
(100 %)
2 diff
(99.7 %id)
DC296649 synovial membrane tissue from rheumatioidarthritis .a 217 to 566 1 to 353       353/353
(100 %)
7 diff
(98.1 %id)
DA210554 brain .a 218 to 781 2 to 563   capped   562/562
(100 %)
2 diff
(99.7 %id)
DA211439 brain .a 218 to 771 2 to 555   capped   554/554
(100 %)
1 diff
(99.9 %id)
BX474752   .a 222 to 794 1 to 571     Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 571/571
(100 %)
6 diff
(99.0 %id)
AB209999   .a 223 to 7141 1 to 6918 exact tiling clone,   6918/6918
(100 %)
2 diff
(100.0 %id)
DB636337 testis .a 224 to 941 1 to 715       715/716
(99 %)
14 diff
(98.1 %id)
DA792172 brain .a 225 to 799 2 to 574   capped   573/574
(99 %)
3 diff
(99.5 %id)
DC369207   .a 242 to 593 1 to 351       351/366
(95 %)
3 diff
(99.2 %id)
DA989248 synovial membrane tissue from rheumatioidarthritis .a 242 to 812 2 to 570   capped   569/569
(100 %)
1 diff
(99.9 %id)
DA459114 tongue, tumor tissue .a 247 to 809 2 to 563   capped   562/562
(100 %)
2 diff
(99.7 %id)
DA697876   .a 247 to 827 2 to 581   capped   580/580
(100 %)
3 diff
(99.5 %id)
DC407893 thymus .a 247 to 496 1 to 247       247/247
(100 %)
1 diff
(99.6 %id)
DA443302 tongue, tumor tissue .a 248 to 809 2 to 562   capped   561/561
(100 %)
1 diff
(99.9 %id)
DA558336   .a 254 to 838 2 to 583   capped   582/582
(100 %)
1 diff
(99.9 %id)
BP314632 mammary gland .a 254 to 837 1 to 584       584/584
(100 %)
3 diff
(99.5 %id)
BP312439 mammary gland .a 256 to 838 1 to 583       583/583
(100 %)
4 diff
(99.4 %id)
BP314710 mammary gland .a 261 to 845 1 to 581       581/581
(100 %)
4 diff
(99.4 %id)
DC369631   .a 265 to 719 1 to 456       456/456
(100 %)
5 diff
(99.0 %id)
DA672327   .a 266 to 850 2 to 585   capped   584/584
(100 %)
1 diff
(99.9 %id)
DA720704   .a 266 to 826 2 to 561   capped   560/560
(100 %)
2 diff
(99.7 %id)
DA726772   .a 266 to 821 2 to 556   capped   555/555
(100 %)
2 diff
(99.7 %id)
DA722325   .a 269 to 831 2 to 563   capped   562/562
(100 %)
2 diff
(99.7 %id)
AK307580   .a 271 to 3704 1 to 3433       3433/3433
(100 %)
2 diff
(100.0 %id)
DA727053   .a 272 to 852 2 to 582   capped   581/581
(100 %)
3 diff
(99.5 %id)
BC110916 Testis, embryonal carcinoma .a 282 to 3742 1 to 3457   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 3457/3458
(99 %)
4 diff
(99.9 %id)
AK225060 coronary artery .a 286 to 3741 1 to 3453   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 3453/3453
(100 %)
8 diff
(99.8 %id)
AL710140 human skeletal muscle .a 287 to 972 1 to 684       684/687
(99 %)
5 diff
(99.3 %id)
BE886088 leiomyosarcoma, uterus .a 303 to 1059 1 to 742       742/911
(81 %)
25 diff
(97.3 %id)
DB079061 testis .a 382 to 934 2 to 554   tiling clone, capped   553/553
(100 %)
1 diff
(99.9 %id)
CN419108 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 493 to 1205 1 to 713       713/772
(92 %)
3 diff
(99.7 %id)
CN419110 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 528 to 1090 1 to 563       563/563
(100 %)
0 diff
(100 %id)
AU141006 placenta .a 829 to 1635 2 to 809   capped   808/808
(100 %)
6 diff
(99.3 %id)
CA848555 Pancreas, Purified pancreatic islet .a 882 to 1211 1 to 332   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 332/414
(80 %)
23 diff
(94.5 %id)
T07054   .a 910 to 1195 1 to 292       290/294
(98 %)
8 diff
(97.3 %id)
BU180941 large cell carcinoma, lung .a 983 to 1818 1 to 844       844/884
(95 %)
23 diff
(97.4 %id)
CN419114 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 1016 to 1693 1 to 678       678/678
(100 %)
0 diff
(100 %id)
BE896367 melanotic melanoma, skin .a 1037 to 1714 1 to 682       682/1101
(61 %)
16 diff
(98.6 %id)
BF760228 colon .a 1145 to 1537 396 to 4     Submitted on the opposite strand 393/396
(99 %)
0 diff
(100 %id)
DA457165 tongue, tumor tissue .a 1210 to 1777 2 to 569   capped   568/568
(100 %)
1 diff
(99.9 %id)
BQ070205 brain, neuroblastoma, cell line .a 1210 to 2080 7 to 888       884/1021
(86 %)
25 diff
(97.6 %id)
CR993766 T-Lymphocytes .a 1224 to 2074 1 to 855       855/857
(99 %)
12 diff
(98.6 %id)
W26024 eye, retina .a 1298 to 1743 477 to 24       454/558
(81 %)
18 diff
(96.8 %id)
DB001758 breast, tumor tissue .a 1359 to 1892 2 to 535   capped   534/534
(100 %)
0 diff
(100 %id)
BG777029 lung, mucoepidermoid carcinoma .a 1372 to 1993 1 to 623       623/623
(100 %)
2 diff
(99.7 %id)
BU501376 eye, normal pigmented retinal epithelium .a 1388 to 2210 1 to 829       829/935
(88 %)
23 diff
(97.6 %id)
TI_154154359   .a 1455 to 2090 80 to 715       636/642
(99 %)
7 diff
(99.0 %id)
DA555519   .a 1490 to 1981 2 to 493   capped   492/492
(100 %)
0 diff
(100 %id)
BP275220 Kidney .a 1563 to 2144 1 to 581       581/581
(100 %)
5 diff
(99.2 %id)
CN419112 embryonic stem cells, DMSO-treated H9 cellline .a 1564 to 1964 1 to 401       401/401
(100 %)
0 diff
(100 %id)
BG287795 bladder, transitional cell papilloma, cell line .a 1721 to 2383 1 to 660       660/713
(92 %)
8 diff
(98.9 %id)
BQ320165 colon .a 1743 to 2090 360 to 14       347/360
(96 %)
1 diff
(99.8 %id)
BP253943 Kidney .a 1796 to 2377 1 to 582       582/582
(100 %)
1 diff
(99.9 %id)
FN092698 breast carcinoma .a 1839 to 1938 101 to 1     Submitted on the opposite strand 101/101
(100 %)
1 diff
(99.1 %id)
AW604275 colon .a 1847 to 2358 1 to 512       512/512
(100 %)
0 diff
(100 %id)
BU169448 large cell carcinoma, lung .a 2161 to 2936 1 to 786       786/921
(85 %)
24 diff
(97.4 %id)
DA769934 brain .a 2286 to 2855 2 to 571   capped   570/570
(100 %)
1 diff
(99.9 %id)
FN087659 breast carcinoma .a 2296 to 2353 9 to 66       58/66
(87 %)
6 diff
(91.0 %id)
DR760012 embryonic stem .a 2557 to 3250 1 to 694       694/694
(100 %)
0 diff
(100 %id)
TI_154165202   .a 2590 to 3330 80 to 824       745/794
(93 %)
32 diff
(96.0 %id)
BE882996 leiomyosarcoma, uterus .a 2591 to 3306 1 to 716       716/718
(99 %)
8 diff
(98.9 %id)
FN176552 breast carcinoma .a 2735 to 2830 97 to 1     Submitted on the opposite strand 97/97
(100 %)
1 diff
(99.0 %id)
BQ935277 brain, neuroblastoma, cell line .a 2769 to 3660 1 to 892       892/941
(94 %)
17 diff
(98.2 %id)
DA787584 brain .a 2811 to 3394 2 to 584   capped   583/583
(100 %)
3 diff
(99.5 %id)
FN058770 breast carcinoma .a 2857 to 2912 56 to 1     Submitted on the opposite strand 56/57
(98 %)
0 diff
(100 %id)
BQ924973 large cell carcinoma, lung .a 2880 to 3742 1 to 862   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 862/863
(99 %)
6 diff
(99.4 %id)
AJ713599 bone marrow .a 2884 to 3120 1 to 237       237/237
(100 %)
0 diff
(100 %id)
BP255745 Kidney .a 2891 to 3475 1 to 585       585/585
(100 %)
1 diff
(99.9 %id)
CA308399 Alveolar Macrophage, lung .a 2938 to 3737 802 to 3   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 800/802
(99 %)
1 diff
(99.9 %id)
BM474378 leiomyosarcoma, uterus .a 2951 to 3743 1 to 795       795/795
(100 %)
6 diff
(99.3 %id)
CD300395 testis .a 2980 to 3823 32 to 878       847/878
(96 %)
14 diff
(98.5 %id)
DB076028 testis .a 2988 to 3521 2 to 535   capped   534/534
(100 %)
0 diff
(100 %id)
AL133922 amygdala .a 3034 to 3730 703 to 1       701/705
(99 %)
8 diff
(98.9 %id)
DB066642 testis .a 3065 to 3602 2 to 539   capped   538/538
(100 %)
0 diff
(100 %id)
BQ285911 Pancreas, Purified pancreatic islet .a 3096 to 3725 630 to 1       630/630
(100 %)
0 diff
(100 %id)
BP286336 lung .a 3116 to 3695 1 to 580       580/582
(99 %)
1 diff
(99.9 %id)
FN063222 breast carcinoma .a 3129 to 3232 99 to 1     Submitted on the opposite strand 99/99
(100 %)
0 diff
(100 %id)
FN087259 breast carcinoma .a 3134 to 3233 103 to 1     Submitted on the opposite strand 103/103
(100 %)
3 diff
(97.1 %id)
BF757252 colon .a 3184 to 3657 474 to 1     Submitted on the opposite strand 474/474
(100 %)
1 diff
(99.8 %id)
BX474753   .a 3189 to 3742 561 to 8   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 554/561
(98 %)
0 diff
(100 %id)
FN050503 breast carcinoma .a 3252 to 3341 1 to 90       90/90
(100 %)
0 diff
(100 %id)
CN419109 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 3308 to 4024 1 to 717       717/717
(100 %)
0 diff
(100 %id)
FN109251 breast carcinoma .a 3341 to 3424 1 to 84       84/84
(100 %)
5 diff
(94.1 %id)
DA031612   .a 3377 to 3963 2 to 588   capped   587/587
(100 %)
0 diff
(100 %id)
AW468600 myeloid cells, 18 pooled CML cases, BCR/ABLrearrangement positive, includes both chronic phase andmyeloid blast crisis, whole blood .a 3379 to 3726 348 to 1       348/348
(100 %)
0 diff
(100 %id)
BE328608 2 pooled Wilms' tumors, one primary and onemetastatic to brain, Kidney .a 3379 to 3727 349 to 1       349/349
(100 %)
0 diff
(100 %id)
CD522889 pooled .a 3468 to 4217 1 to 757       757/826
(91 %)
15 diff
(98.2 %id)
CN419115 embryonic stem cells, DMSO-treated H9 cellline .a 3508 to 4094 1 to 588       588/588
(100 %)
2 diff
(99.7 %id)
DA154564 amygdala .a 3543 to 4102 2 to 561   capped   560/560
(100 %)
0 diff
(100 %id)
FN172826 breast carcinoma .a 3585 to 3695 109 to 1     Submitted on the opposite strand 109/109
(100 %)
4 diff
(96.4 %id)
DR977873 brain .a 3589 to 3700 1 to 110   AAA Submitted on the opposite strand 110/119
(92 %)
4 diff
(96.7 %id)
DR980076 placenta .a 3589 to 3721 1 to 132   AAA Submitted on the opposite strand 132/132
(100 %)
4 diff
(97.0 %id)
DR980700 placenta .a 3589 to 3721 1 to 132   AAA Submitted on the opposite strand 132/132
(100 %)
3 diff
(97.8 %id)
GD136859   .a 3592 to 3710 1 to 120   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 120/124
(96 %)
6 diff
(95.2 %id)
EC440286 Prostate .a 3607 to 3725 119 to 3     Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 117/119
(98 %)
0 diff
(100 %id)
EC455328 Prostate .a 3607 to 3725 118 to 3     Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 116/118
(98 %)
0 diff
(100 %id)
DA444690 tongue, tumor tissue .a 3657 to 4240 2 to 585   capped   584/585
(99 %)
1 diff
(99.9 %id)
DA639530 Liver .a 3716 to 4266 2 to 552   capped   551/551
(100 %)
0 diff
(100 %id)
BP326032 prostata .a 3722 to 4307 1 to 583       583/583
(100 %)
3 diff
(99.5 %id)
AU140331 placenta .a 3729 to 4627 2 to 900   capped   899/902
(99 %)
9 diff
(99.1 %id)
BP319401 pericardium .a 3737 to 4319 1 to 583       583/583
(100 %)
2 diff
(99.7 %id)
FN143595 breast carcinoma .a 3776 to 3847 1 to 72       72/73
(98 %)
4 diff
(94.6 %id)
DB191873 ovary, tumor tissue .a 3888 to 4443 2 to 557   capped   556/556
(100 %)
0 diff
(100 %id)
BE901134 choriocarcinoma, placenta .a 3908 to 4736 1 to 828       828/916
(90 %)
16 diff
(98.3 %id)
BE901836 choriocarcinoma, placenta .a 3909 to 4669 1 to 761       761/936
(81 %)
18 diff
(98.1 %id)
DA175997 amygdala .a 3921 to 4494 2 to 576   capped   575/575
(100 %)
1 diff
(99.9 %id)
DA969510 stomach .a 4017 to 4499 2 to 484   capped   483/483
(100 %)
0 diff
(100 %id)
CU448907 epidermis .a 4035 to 4445 18 to 429       412/445
(92 %)
6 diff
(98.7 %id)
CU449572 epidermis .a 4035 to 4445 18 to 429       412/445
(92 %)
6 diff
(98.7 %id)
CX781730 human embryonic stem cells .a 4058 to 4835 1 to 778       778/778
(100 %)
0 diff
(100 %id)
BE535444 cervix .a 4109 to 4797 1 to 690       690/690
(100 %)
2 diff
(99.8 %id)
CR979726 T-Lymphocytes .a 4233 to 5050 1 to 815       815/821
(99 %)
6 diff
(99.3 %id)
CR996515 T-Lymphocytes .a 4248 to 5183 1 to 937       937/943
(99 %)
7 diff
(99.3 %id)
DB202599 trachea .a 4311 to 4876 2 to 567   capped   566/566
(100 %)
0 diff
(100 %id)
BG675088 skin .a 4326 to 5124 1 to 801       801/804
(99 %)
15 diff
(98.2 %id)
BQ720651 sympathetic trunk .a 4376 to 5111 1 to 741   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 741/968
(76 %)
14 diff
(98.6 %id)
BF753685 colon .a 4413 to 4648 236 to 1     Submitted on the opposite strand 236/240
(98 %)
7 diff
(97.1 %id)
CR995561 T-Lymphocytes .a 4415 to 5245 1 to 835       835/835
(100 %)
15 diff
(98.3 %id)
TI_154018624   .a 4437 to 5134 759 to 63       697/759
(91 %)
0 diff
(100 %id)
BP311527 brain .a 4447 to 5029 1 to 583       583/583
(100 %)
1 diff
(99.9 %id)
BQ028154 mixed .a 4448 to 5128 681 to 5   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 677/681
(99 %)
3 diff
(99.6 %id)
CA942559 Pancreas, Purified pancreatic islet .a 4455 to 5099 1 to 645   fully sequenced,   645/645
(100 %)
4 diff
(99.4 %id)
CA437681 lung, Metastatic Chondrosarcoma .a 4458 to 5119 662 to 1       662/662
(100 %)
0 diff
(100 %id)
U25911   .a 4486 to 4857 1 to 372       372/372
(100 %)
0 diff
(100 %id)
BQ937536 leiomyosarcoma, uterus .a 4492 to 5358 1 to 871       871/895
(97 %)
15 diff
(98.4 %id)
FN131599 breast carcinoma .a 4516 to 4619 107 to 1     Submitted on the opposite strand 107/107
(100 %)
3 diff
(97.2 %id)
DA615620   .a 4576 to 5148 2 to 574   capped   573/573
(100 %)
1 diff
(99.9 %id)
CU455919 epidermis .a 4581 to 5110 539 to 9     Submitted on the opposite strand 531/559
(94 %)
2 diff
(99.7 %id)
BP203074 coronary artery .a 4629 to 5128 1 to 499   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 499/509
(98 %)
7 diff
(98.7 %id)
BM833997 stomach .a 4631 to 5126 1 to 496       496/496
(100 %)
0 diff
(100 %id)
CA867260 Pancreas, Purified pancreatic islet .a 4638 to 5113 476 to 1   fully sequenced,   476/476
(100 %)
0 diff
(100 %id)
DW465361 Liver .a 4647 to 4987 17 to 358       342/358
(95 %)
8 diff
(97.8 %id)
BF684838 leiomyosarcoma cell line, uterus .a 4709 to 5557 1 to 862       862/1094
(78 %)
47 diff
(95.8 %id)
CR983193 T-Lymphocytes .a 4914 to 5787 1 to 875       875/875
(100 %)
3 diff
(99.7 %id)
T60896 ovary .a 4962 to 5176 215 to 1     Submitted on the opposite strand 215/215
(100 %)
2 diff
(99.1 %id)
FN107001 breast carcinoma .a 4996 to 5099 1 to 105       105/108
(97 %)
4 diff
(96.3 %id)
BE265352 lung, small cell carcinoma .a 4998 to 5572 1 to 575       575/575
(100 %)
4 diff
(99.4 %id)
N70444 liver and spleen .a 4999 to 5175 177 to 1       177/177
(100 %)
0 diff
(100 %id)
FN104137 breast carcinoma .a 5018 to 5099 1 to 80       80/82
(97 %)
3 diff
(96.4 %id)
FN158464 breast carcinoma .a 5018 to 5090 1 to 76       76/76
(100 %)
3 diff
(96.1 %id)
BE799330 lung, small cell carcinoma .a 5085 to 5712 24 to 650       627/650
(96 %)
10 diff
(98.5 %id)
CB158792 Liver .a 5136 to 5698 1 to 563       563/563
(100 %)
1 diff
(99.9 %id)
BP226138   .a 5182 to 5763 1 to 581       581/581
(100 %)
5 diff
(99.2 %id)
BP290539 lung .a 5218 to 5780 1 to 563       563/563
(100 %)
2 diff
(99.7 %id)
CD685783 normal nasopharynx .a 5224 to 5905 33 to 714       682/714
(95 %)
7 diff
(99.1 %id)
DB239786 trachea .a 5477 to 6063 2 to 588   capped   587/587
(100 %)
0 diff
(100 %id)
FN090214 breast carcinoma .a 5507 to 5601 1 to 92       92/93
(98 %)
3 diff
(96.8 %id)
TI_149276956   .a 5636 to 6313 760 to 84   AAA Possibly primed on the genome, locally A rich (11/11 A in genome downstream of last aligned base) 677/677
(100 %)
1 diff
(99.9 %id)
BF843709 head_neck .a 5658 to 6125 465 to 1     Submitted on the opposite strand 465/467
(99 %)
17 diff
(96.4 %id)
BF844636 head_neck .a 5658 to 6145 488 to 5     Submitted on the opposite strand 484/490
(98 %)
0 diff
(100 %id)
BM969065 lung, Primary Lung Epithelial Cells .a 5658 to 6313 674 to 19   AAA Possibly primed on the genome, locally A rich (11/11 A in genome downstream of last aligned base) 656/656
(100 %)
0 diff
(100 %id)
AI866620 brain, tumor, 5 pooled (see description) .a 5679 to 6314 636 to 1       636/636
(100 %)
7 diff
(98.9 %id)
FN101971 breast carcinoma .a 5683 to 5775 93 to 1     Submitted on the opposite strand 93/97
(95 %)
0 diff
(100 %id)
AI890038 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .a 5683 to 6323 641 to 1       641/641
(100 %)
1 diff
(99.9 %id)
BQ709163 Spleen .a 5692 to 6627 982 to 46   AAA Submitted on the opposite strand 937/939
(99 %)
34 diff
(96.4 %id)
BF507457   .a 5725 to 6313 607 to 18   AAA Possibly primed on the genome, locally A rich (11/11 A in genome downstream of last aligned base) 590/591
(99 %)
1 diff
(99.9 %id)
BE301184 Kidney, renal cell adenocarcinoma .a 5727 to 6315 589 to 1       589/589
(100 %)
0 diff
(100 %id)
BQ326282 colon_normal .a 5798 to 6242 448 to 4       445/448
(99 %)
0 diff
(100 %id)
BF196524 Kidney .a 5798 to 6313 516 to 1       516/516
(100 %)
0 diff
(100 %id)
TI_154093424   .a 5802 to 6627 916 to 100   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 817/985
(82 %)
31 diff
(96.9 %id)
TI_154107225   .a 5808 to 6627 902 to 88   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 815/971
(83 %)
8 diff
(99.2 %id)
BP294550 Liver .a 5816 to 6261 1 to 446       446/446
(100 %)
0 diff
(100 %id)
AI146438 heart .a 5820 to 6314 495 to 1       495/495
(100 %)
0 diff
(100 %id)
AW182989 pooled .a 5847 to 6294 448 to 1       448/448
(100 %)
0 diff
(100 %id)
AI189146 placenta .a 5855 to 6631 771 to 1       771/771
(100 %)
27 diff
(96.5 %id)
CA446992 Chondrosarcoma, Left Pubic Bone .a 5927 to 6627 720 to 19   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 702/702
(100 %)
1 diff
(99.9 %id)
DB514035 testis .a 5932 to 6627 1 to 696   AAA Submitted on the opposite strand 696/696
(100 %)
11 diff
(98.5 %id)
AI972293 Prostate .a 5933 to 6313 381 to 1       381/381
(100 %)
0 diff
(100 %id)
BF475982 Prostate .a 5933 to 6313 381 to 1       381/381
(100 %)
0 diff
(100 %id)
BE676314 B-cell, chronic lymphotic leukemia .a 5972 to 6633 662 to 1       662/662
(100 %)
3 diff
(99.6 %id)
BQ003662 Chondrosarcoma, Left Pelvis .a 5980 to 6627 667 to 19   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 649/649
(100 %)
1 diff
(99.9 %id)
BQ447798 Knee, Osteoarthritic Cartilage .a 5992 to 6627 654 to 19   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 636/636
(100 %)
4 diff
(99.4 %id)
BM931963 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .a 6010 to 6540 1 to 533   fully sequenced,   533/533
(100 %)
1 diff
(99.9 %id)
AI693257 carcinoid, lung .a 6020 to 6627 608 to 1       608/612
(99 %)
3 diff
(99.6 %id)
DA798146 brain .a 6023 to 6575 2 to 555   capped   554/554
(100 %)
3 diff
(99.5 %id)
BM998157 lung, Metastatic Chondrosarcoma .a 6036 to 6627 609 to 19   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 591/591
(100 %)
1 diff
(99.9 %id)
CA435251 Fibrosarcoma .a 6037 to 6627 610 to 19   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 592/592
(100 %)
4 diff
(99.4 %id)
CN344948 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 6042 to 6591 550 to 1     Submitted on the opposite strand 550/550
(100 %)
0 diff
(100 %id)
FN061446 breast carcinoma .a 6064 to 6137 1 to 74       74/74
(100 %)
3 diff
(96.0 %id)
AI682230 pooled .a 6071 to 6630 558 to 1       558/558
(100 %)
5 diff
(99.2 %id)
BQ070077 brain, neuroblastoma, cell line .a 6090 to 6168 795 to 883       830/1002
(82 %)
35 diff
(96.6 %id)
AU158427 placenta .a 6093 to 6627 534 to 1       534/536
(99 %)
10 diff
(98.2 %id)
BM984454 lung, Primary Lung Epithelial Cells .a 6135 to 6621 19 to 505     Submitted on the opposite strand 487/513
(94 %)
3 diff
(99.5 %id)
BF906676 stomach .a 6139 to 6366 227 to 1     Submitted on the opposite strand 227/228
(99 %)
10 diff
(95.7 %id)
BE673745 carcinoid, lung .a 6144 to 6825 681 to 1   tiling clone,   681/681
(100 %)
4 diff
(99.5 %id)
BE044209 pooled .a 6214 to 6632 419 to 1       419/419
(100 %)
0 diff
(100 %id)
TI_159723456   .a 6231 to 6627 56 to 453   AAA Submitted on the opposite strand 398/453
(87 %)
6 diff
(98.7 %id)
AI700672 carcinoid, lung .a 6249 to 6608 1 to 360     Submitted on the opposite strand 360/360
(100 %)
0 diff
(100 %id)
FN073791 breast carcinoma .a 6253 to 6313 1 to 61       61/61
(100 %)
0 diff
(100 %id)
N20368 melanocyte .a 6329 to 6557 1 to 229       229/229
(100 %)
0 diff
(100 %id)
AI492362 Kidney .a 6340 to 6634 295 to 1       295/295
(100 %)
0 diff
(100 %id)
AA906265 pooled .a 6346 to 6638 293 to 1       293/293
(100 %)
0 diff
(100 %id)
AW300068 Kidney .a 6362 to 6627 266 to 1       266/266
(100 %)
0 diff
(100 %id)
AW949803   .a 6375 to 6981 1 to 608       608/608
(100 %)
5 diff
(99.2 %id)
FN096954 breast carcinoma .a 6379 to 6469 1 to 90       90/93
(96 %)
4 diff
(95.7 %id)
AA129842 lung, lung carcinoma .a 6398 to 6629 1 to 232   fully sequenced,   232/232
(100 %)
2 diff
(99.2 %id)
AI393285 B-cell, chronic lymphotic leukemia .a 6407 to 6635 229 to 1       229/229
(100 %)
0 diff
(100 %id)
AA128422 lung, lung carcinoma .a 6442 to 6628 187 to 1   fully sequenced,   187/187
(100 %)
0 diff
(100 %id)
FN137926 breast carcinoma .a 6454 to 6551 100 to 3     Submitted on the opposite strand 98/100
(98 %)
0 diff
(100 %id)
BQ015222 Chondrosarcoma, Left Pubic Bone .a 6476 to 7163 698 to 13   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 686/686
(100 %)
2 diff
(99.8 %id)
BM685004 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .a 6510 to 6835 333 to 1   fully sequenced,   333/333
(100 %)
5 diff
(98.5 %id)
FN164550 breast carcinoma .a 6512 to 6609 97 to 1     Submitted on the opposite strand 97/97
(100 %)
2 diff
(98.0 %id)
GD148867   .a 6557 to 6627 1 to 71   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 71/71
(100 %)
3 diff
(95.8 %id)
EL947892 eyeball .a 6692 to 7177 1 to 486   tiling clone, AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 486/486
(100 %)
2 diff
(99.6 %id)
AW304389 lung, two pooled squamous cell carcinomas .a 6770 to 7175 406 to 1       406/406
(100 %)
0 diff
(100 %id)
DA703243   .a 6857 to 7355 2 to 500   capped   499/499
(100 %)
0 diff
(100 %id)
AI634822 Kidney .a 6884 to 7405 522 to 1       522/522
(100 %)
0 diff
(100 %id)
AA952997 pooled .a 7042 to 7405 364 to 1       364/364
(100 %)
0 diff
(100 %id)
AL133026 testis .a 7139 to 10833 1 to 3695   tiling clone, available from DKFZ, AAA Possibly primed on the genome, locally A rich (11/11 A in genome downstream of last aligned base) 3695/3695
(100 %)
3 diff
(100.0 %id)
DA859315 placenta .a 7166 to 7731 2 to 567   capped   566/566
(100 %)
2 diff
(99.7 %id)
DA133887 alzheimer cortex .a 7427 to 7982 2 to 557   capped   556/556
(100 %)
0 diff
(100 %id)
DB052632 testis .a 7522 to 8086 2 to 567   capped   566/566
(100 %)
1 diff
(99.9 %id)
DB260115 uterus .a 7583 to 8169 2 to 588   capped   587/587
(100 %)
0 diff
(100 %id)
AK057703 uterus .a 7627 to 9353 1 to 1727   tiling clone, available from FLJ,   1727/1727
(100 %)
0 diff
(100 %id)
DB247301 uterus .a 7628 to 8394 2 to 766   capped   765/766
(99 %)
3 diff
(99.7 %id)
DA864132 placenta .a 7673 to 8272 2 to 602   capped   601/601
(100 %)
1 diff
(99.9 %id)
DA532927 brain .a 7732 to 8302 2 to 572   capped   571/571
(100 %)
1 diff
(99.9 %id)
BQ434792 melanotic melanoma, skin .a 7865 to 8754 1 to 893       893/894
(99 %)
12 diff
(98.7 %id)
BM699315 eye, fetal eyes .a 7871 to 8412 1 to 542       542/542
(100 %)
0 diff
(100 %id)
EH349680   .a 7874 to 7954 1 to 81       81/81
(100 %)
0 diff
(100 %id)
DA566863 heart .a 8251 to 8805 2 to 556   capped   555/555
(100 %)
0 diff
(100 %id)
DA666301   .a 8295 to 8860 2 to 567   capped   566/566
(100 %)
1 diff
(99.9 %id)
DA646091 mammary gland .a 8314 to 9153 2 to 838   capped   837/841
(99 %)
7 diff
(99.2 %id)
CB158627 Liver .a 8330 to 8802 1 to 473       473/473
(100 %)
0 diff
(100 %id)
DA089445 cerebellum .a 8345 to 8679 2 to 336   capped   335/335
(100 %)
0 diff
(100 %id)
BM718581 eye, fetal eye .a 8425 to 8873 1 to 450     Possibly primed on the genome, locally A rich (11/11 A in genome downstream of last aligned base) 450/450
(100 %)
1 diff
(99.8 %id)
AA053435 colon, tumor .a 8466 to 8885 1 to 422       422/423
(99 %)
4 diff
(99.1 %id)
F12033 brain, total brain .a 8508 to 8789 1 to 280       280/280
(100 %)
4 diff
(98.6 %id)
BM728298 eye, fetal eye .a 8525 to 8978 1 to 454     Possibly primed on the genome, locally A rich (11/11 A in genome downstream of last aligned base) 454/454
(100 %)
0 diff
(100 %id)
T65636 whole brain .a 8566 to 8782 1 to 217       217/217
(100 %)
0 diff
(100 %id)
BE502354 pooled germ cell tumors .a 8794 to 9357 565 to 1       565/565
(100 %)
1 diff
(99.9 %id)
AW612682 carcinoid, lung .a 8796 to 9357 568 to 7       562/568
(98 %)
0 diff
(100 %id)
AA703247 liver and spleen .a 8800 to 9353 555 to 2       554/555
(99 %)
0 diff
(100 %id)
CF454152 peripheral nervous system .a 8846 to 9554 24 to 733       710/733
(96 %)
6 diff
(99.2 %id)
DB350877 uterus .a 8896 to 9353 461 to 1       461/461
(100 %)
7 diff
(98.5 %id)
AA052952 colon, tumor .a 8927 to 9351 426 to 1       426/426
(100 %)
1 diff
(99.8 %id)
AW292586   .a 8960 to 9356 414 to 18   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 397/397
(100 %)
0 diff
(100 %id)
CK825261 Pancreas, Purified pancreatic islet .a 9168 to 9716 1 to 550     Submitted on the opposite strand 550/550
(100 %)
1 diff
(99.9 %id)
BQ956136 sciatic nerve .a 9233 to 10087 1 to 866       866/920
(94 %)
23 diff
(97.5 %id)
BU615927 Bone, Subchondral Bone .a 9307 to 10068 776 to 19   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 758/758
(100 %)
6 diff
(99.3 %id)
TI_149285568   .a 9392 to 10068 795 to 120   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 676/676
(100 %)
12 diff
(98.3 %id)
BE774684 uterus .a 9492 to 9646 159 to 6       154/167
(92 %)
0 diff
(100 %id)
DB360724 mammary gland .a 9497 to 10073 571 to 1       571/573
(99 %)
14 diff
(97.6 %id)
TI_59393767   .a 9518 to 10072 89 to 643       555/652
(85 %)
8 diff
(98.8 %id)
AI672662 thymus, pooled .a 9577 to 10073 497 to 1       497/497
(100 %)
0 diff
(100 %id)
AW178885 stomach .a 9600 to 9896 319 to 24       296/319
(92 %)
0 diff
(100 %id)
AW444590   .a 9621 to 10068 465 to 18   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 448/448
(100 %)
0 diff
(100 %id)
AI797502 pooled .a 9654 to 10069 416 to 1       416/416
(100 %)
0 diff
(100 %id)
D79404 aorta .a 9746 to 9987 1 to 242       242/242
(100 %)
0 diff
(100 %id)
D62301   .a 9746 to 10034 1 to 289       289/289
(100 %)
0 diff
(100 %id)
D79473 aorta .a 9746 to 9999 1 to 254       254/254
(100 %)
0 diff
(100 %id)
D62344   .a 9746 to 10052 1 to 307       307/307
(100 %)
0 diff
(100 %id)
F09678 brain, total brain .a 9786 to 10068 283 to 1       283/283
(100 %)
1 diff
(99.7 %id)
H67936 liver and spleen .a 9793 to 10075 285 to 2     Submitted on the opposite strand 284/285
(99 %)
0 diff
(100 %id)
BU742840 eye, fetal eye .a 9866 to 10594 747 to 19   AAA Possibly primed on the genome, locally A rich (11/11 A in genome downstream of last aligned base) 729/729
(100 %)
2 diff
(99.8 %id)
AW131815 brain, medulloblastoma .a 9868 to 10079 212 to 1       212/212
(100 %)
0 diff
(100 %id)
AI569801 Kidney .a 9869 to 10068 210 to 11   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 200/200
(100 %)
0 diff
(100 %id)
AW235718 pooled germ cell tumors .a 9891 to 10071 181 to 1       181/181
(100 %)
0 diff
(100 %id)
FN169748 breast carcinoma .a 9948 to 10049 1 to 101       101/101
(100 %)
1 diff
(99.1 %id)
CK825262 Pancreas, Purified pancreatic islet .a 9984 to 10600 617 to 1     Submitted on the opposite strand 617/617
(100 %)
0 diff
(100 %id)
BM310524 Pancreas, Purified pancreatic islet .a 10005 to 10593 589 to 1       589/589
(100 %)
0 diff
(100 %id)
BU743019 eye, fetal eye .a 10097 to 10839 747 to 19   AAA Possibly primed on the genome, locally A rich (11/11 A in genome downstream of last aligned base) 729/753
(96 %)
16 diff
(97.9 %id)
W16898 lung .a 10294 to 10620 1 to 336   fully sequenced,   336/336
(100 %)
8 diff
(97.7 %id)
W74352 heart .a 10321 to 10776 1 to 459       459/459
(100 %)
3 diff
(99.4 %id)
AW977593   .a 10326 to 10817 492 to 1     Submitted on the opposite strand 492/492
(100 %)
12 diff
(97.6 %id)
AA854032   .a 10337 to 10824 504 to 17   AAA Possibly primed on the genome, locally A rich (11/11 A in genome downstream of last aligned base) 488/488
(100 %)
0 diff
(100 %id)
CB139655 Liver .a 10344 to 10764 1 to 421       421/421
(100 %)
0 diff
(100 %id)
AI884688 anaplastic oligodendroglioma, brain .a 10392 to 10906 529 to 15   tiling clone, AAA Possibly primed on the genome, locally A rich (11/11 A in genome downstream of last aligned base) 515/515
(100 %)
0 diff
(100 %id)
AI017036 Kidney .a 10439 to 10844 406 to 1       406/406
(100 %)
0 diff
(100 %id)
AI696637 Prostate .a 10568 to 10844 277 to 1       277/277
(100 %)
0 diff
(100 %id)
N80904 lung .a 10590 to 10843 256 to 1   fully sequenced,   256/256
(100 %)
0 diff
(100 %id)
AK301150 Spleen .b 1 to 3316 8 to 3321 M824T tiling clone,   3321/3321
(100 %)
4 diff
(99.9 %id)
DC390268 Spleen .b 1 to 547 8 to 553       553/553
(100 %)
4 diff
(99.3 %id)
AK301273 Spleen .c -9 to 2328 1 to 2336 P431Q M484T tiling clone,   2336/2336
(100 %)
4 diff
(99.9 %id)
DC392005 Spleen .c -9 to 535 1 to 543       543/543
(100 %)
1 diff
(99.9 %id)
BQ707817 Spleen .d 1 to 869 1 to 878   tiling clone,   878/951
(92 %)
33 diff
(96.6 %id)
BQ711250 Spleen .d 815 to 1653 1 to 843   tiling clone,   843/986
(85 %)
12 diff
(98.8 %id)
AA075368   .d 1347 to 1815 1 to 473   fully sequenced,   473/473
(100 %)
5 diff
(99.0 %id)
BQ632596 Pancreas, Purified pancreatic islet .d 1408 to 1841 1 to 434   tiling clone, fully sequenced,   434/434
(100 %)
0 diff
(100 %id)
AA075369   .d 1785 to 2222 441 to 1   tiling clone, fully sequenced,   441/441
(100 %)
7 diff
(98.5 %id)
BQ632303 Pancreas, Purified pancreatic islet .d 1811 to 2220 410 to 1   tiling clone, fully sequenced,   410/410
(100 %)
0 diff
(100 %id)
CA433443 mixed .e 1 to 324 19 to 342   tiling clone, Submitted on the opposite strand 324/332
(97 %)
1 diff
(99.7 %id)
CB145286 Liver .e 32 to 466 450 to 17   AAA Submitted on the opposite strand 434/450
(96 %)
1 diff
(99.8 %id)
CB134128 Liver .e 36 to 466 436 to 7   AAA Submitted on the opposite strand 430/436
(98 %)
9 diff
(98.0 %id)
AW500785 lymph .e 51 to 466 434 to 20   AAA Submitted on the opposite strand 415/439
(94 %)
8 diff
(98.2 %id)
AW997007 breast_normal .e 62 to 589 526 to 1   tiling clone, Submitted on the opposite strand 526/526
(100 %)
5 diff
(99.1 %id)
AA101935 colon, tumor .e 472 to 903 1 to 434   tiling clone,   435/435
(100 %)
9 diff
(98.0 %id)
CT003795 T-Lymphocytes .e 694 to 1362 1 to 669   tiling clone,   669/669
(100 %)
0 diff
(100 %id)
AA101936 colon, tumor .e 1273 to 1735 463 to 1   tiling clone,   463/463
(100 %)
2 diff
(99.6 %id)
DB030927 testis .f 1 to 537 2 to 538   tiling clone, capped   537/537
(100 %)
0 diff
(100 %id)
CR996665 T-Lymphocytes .f 336 to 1251 1 to 918   tiling clone,   918/918
(100 %)
3 diff
(99.7 %id)
AW376920 colon .g 1 to 672 1 to 672 P2S W3R H20L tiling clone,   672/672
(100 %)
15 diff
(97.8 %id)
DB089404 testis .h 1 to 559 2 to 560 exact tiling clone, capped   559/559
(100 %)
1 diff
(99.9 %id)
DC370048   .i-u 1 to 545 1 to 546   tiling clone,   546/546
(100 %)
16 diff
(97.1 %id)
DC335186 hippocampus .i-u 31 to 559 1 to 528   tiling clone,   528/528
(100 %)
1 diff
(99.9 %id)
DC377417 brain .i-u 34 to 506 1 to 473       473/473
(100 %)
0 diff
(100 %id)
CD557459 testis .i-u 52 to 791 1 to 746       746/971
(76 %)
23 diff
(97.7 %id)
BC092417 testis .i-u 57 to 2320 1 to 2263 exact tiling clone, AAA   2263/2263
(100 %)
6 diff
(99.8 %id)
DC309081 cerebellum .i-u 72 to 673 1 to 599   tiling clone,   599/599
(100 %)
1 diff
(99.9 %id)
DC372255   .i-u 72 to 654 1 to 582       582/582
(100 %)
2 diff
(99.7 %id)
DC407658 thymus .i-u 87 to 643 1 to 557       557/557
(100 %)
4 diff
(99.3 %id)
DB066347 testis .i-u 289 to 824 2 to 535   capped   534/534
(100 %)
2 diff
(99.7 %id)
AU311676 neuroblastoma .i-u 1618 to 2196 1 to 579       579/579
(100 %)
2 diff
(99.7 %id)
BE768766 prostate_tumor .j 1 to 382 383 to 2 exact tiling clone,   382/388
(98 %)
2 diff
(99.5 %id)
AW968553   .k-u 1 to 605 1 to 607   tiling clone,   607/609
(99 %)
14 diff
(97.8 %id)
DB345755 thymus .k-u 44 to 594 1 to 551     Submitted on the opposite strand 551/551
(100 %)
2 diff
(99.7 %id)
DT215905 brain .k-u 120 to 795 1 to 676       676/676
(100 %)
1 diff
(99.9 %id)
BX092553   .k-u 357 to 1165 1 to 811   tiling clone,   811/811
(100 %)
3 diff
(99.7 %id)
AA470104   .k-u 357 to 801 1 to 445       445/445
(100 %)
0 diff
(100 %id)
BU182879 melanotic melanoma, skin .k-u 574 to 1373 15 to 819       805/924
(87 %)
27 diff
(97.1 %id)
AW968727   .k-u 693 to 1383 696 to 3     Submitted on the opposite strand 694/697
(99 %)
0 diff
(100 %id)
CD511795 Pooled-Skin .k-u 828 to 1557 1 to 737   tiling clone,   737/772
(95 %)
10 diff
(98.8 %id)
AA469935   .k-u 991 to 1385 395 to 1       395/395
(100 %)
0 diff
(100 %id)
AW027125 thymus, pooled .k-u 1006 to 1386 382 to 4       379/382
(99 %)
0 diff
(100 %id)
AA485247 germinal center B cell .k-u 1020 to 1386 373 to 6       368/373
(98 %)
0 diff
(100 %id)
AA888174 2 pooled tumors (clear cell type), Kidney .k-u 1056 to 1482 429 to 3       427/429
(99 %)
0 diff
(100 %id)
BG435208 placenta .k-u 1398 to 2074 1 to 685   tiling clone,   685/828
(82 %)
23 diff
(97.3 %id)
AF007135 brain .k-u 1788 to 3201 1 to 1414 exact tiling clone, AAA   1414/2022
(69 %)
1 diff
(100.0 %id)
T77477 whole brain .k-u 1811 to 2249 1 to 441       441/442
(99 %)
10 diff
(97.8 %id)
BE835438 prostate_normal .l-u 1 to 565 1 to 565 exact tiling clone,   565/565
(100 %)
1 diff
(99.9 %id)
BF903974 marrow .l-u 347 to 525 184 to 8     Submitted on the opposite strand 177/192
(92 %)
0 diff
(100 %id)
R95054 liver and spleen .m-u 1 to 366 1 to 371   tiling clone, fully sequenced,   371/371
(100 %)
4 diff
(99.0 %id)
R94969 liver and spleen .m-u 336 to 455 127 to 1   tiling clone, fully sequenced,   127/127
(100 %)
0 diff
(100 %id)
BF091439 testis_normal .n-u 1 to 368 1 to 369 F2V L5A S6H H7M V8F ... tiling clone,   369/369
(100 %)
14 diff
(96.3 %id)
AK307689 thymus Gene KDM5A, variant not shown         This clone was ignored    
S66431   Gene KDM5A, variant not shown       AAA This clone was ignored    
DC406434 thymus Gene KDM5A, variant not shown         This clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i-u, .j, .k-u, .l-u, .m-u, .n-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI